A Florida based capital group and SGTM to pursue master license, production scale-up, and multi-year purchase agreement under a signed letter of intent. ASTATULA, FL / ACCESS Newswire / July 9, 2026 / ...

The global biochar market is expected to be valued at US$ 910.4 million in 2026 and projected to reach US$ 2,748.6 million by 2033, expanding at a CAGR of 17.1% during the forecast period. This strong ...

Soil’ project builds resilience and creates economic incentives through sustainable fertiliser production Paul Trainer M.A. Presse- und Öffentlichkeitsa ...

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' ...

A team of students from Bangkok University's School of Entrepreneurship and Management (BUSEM) has won first place at the Babson Collaborative Global Student Challenge 2026, an international ...

Canadian biomass energy firm CHAR Technologies has welcomed the Québec government's new integrated energy plan, which ...

India’s agriculture faces a serious paradox: a large amount of biomass that could improve soil health is instead being burned. This threatens soil health and food security. Punjab and Haryana burn ...

N ew 10-year agreement to explore the commercialization of engineered biochar through innovative, sustainable cold paving solutions ...

HIGHLAND PARK Fla. — A Florida nonprofit is on a mission to revive the state’s farmland with sustainability in mind. Biotech Applied Research is turning waste into “biochar,” a charcoal-like material.

It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local ...

A two-day Agriculture and Biochar Preparation Training Camp was organised at Powaimukh Janajati ME School in Margherita under Assam's Tinsukia district on June 28 and 29 to promote sustainable farming ...

A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at overseas clinics to bypass FDA rules ...